Radical Prostatectomy Shifting to Higher-Risk Cases in Era of Active Surveillance Radical Prostatectomy Shifting to Higher-Risk Cases in Era of Active Surveillance
There has been a trend towards increasing use of radical prostatectomy in men with unfavorable-intermediate- and high-risk disease, according to a time-trends analysis.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - June 16, 2021 Category: Surgery Tags: Hematology-Oncology News Source Type: news

Adjuvant RT May Aid Men at High Risk for Death From Prostate Cancer
WEDNESDAY, June 16, 2021 -- For men with positive pelvic lymph nodes (pN1) or pGleason score 8 to 10 prostate cancer and disease extending beyond the prostate (pT3/4) at radical prostatectomy (RP), adjuvant radiation therapy (RT) versus early... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 16, 2021 Category: Pharmaceuticals Source Type: news

Pelvic Strength Helps Determine When Continence Returns After Radical Prostatectomy Pelvic Strength Helps Determine When Continence Returns After Radical Prostatectomy
Assessment of pelvic-floor strength before radical prostatectomy may allow for more accurate prediction of early return of continence after surgery, new research indicates.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - June 1, 2021 Category: Surgery Tags: Urology News Source Type: news

New device helps restore penile length and sexual function after prostate cancer surgery
(Wolters Kluwer Health) A new type of penile traction therapy (PTT) device can increase penile length and preserve erectile function in men who have undergone prostate cancer surgery (prostatectomy), reports a clinical trial in The Journal of Urology ® , Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 1, 2021 Category: International Medicine & Public Health Source Type: news

Einstein Researchers Develop Novel Drug That Regenerates Erectile Nerves Damaged by Prostate Surgery
April 19, 2021—(BRONX, NY)—Researchers atAlbert Einstein College of Medicine have developed a topical drug that regenerates and restores the function of erectile nerves damaged by radical prostatectomy, the most common treatment for localized prostate cancer. The drug was tested in rats, and the findings were published online today inJCI Insight. (Source: Einstein News)
Source: Einstein News - April 19, 2021 Category: Universities & Medical Training Source Type: news

Novel drug regenerates erectile nerves damaged by prostate surgery
(Albert Einstein College of Medicine) Researchers at Albert Einstein College of Medicine have developed a topical drug that regenerates and restores the function of erectile nerves damaged by radical prostatectomy, the most common treatment for localized prostate cancer. The drug was tested in rats, and the findings were published online today in JCI Insight. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 19, 2021 Category: Cancer & Oncology Source Type: news

Janssen to Highlight Robust Solid Tumor Portfolio and Pipeline at 2021 ASCO GU
February 2, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today it will highlight the depth of its solid tumor portfolio at the American Society of Clinical Oncology Genitourinary (ASCO GU) Cancers Symposium with 12 data presentations, including three company-sponsored oral presentations from the ERLEADA® (apalutamide) clinical development program. The virtual meeting will take place February 11-13, 2021. “We are committed to the development of innovative therapies for patients with genitourinary cancers for whom there remains a high unmet need,” said Craig Tendler, M...
Source: Johnson and Johnson - February 2, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

Postprostatectomy Urinary Outcomes Vary Widely by Patient and Surgeon Postprostatectomy Urinary Outcomes Vary Widely by Patient and Surgeon
Patient-reported urinary outcomes three months after radical prostatectomy vary by patient and by surgeon, and a new study suggests that outcomes may be better with top-performing surgeons.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - January 28, 2021 Category: Surgery Tags: Hematology-Oncology News Source Type: news

What to Expect After Prostate Is Removed
What Is the Difference Between Prostatectomy vs. Radical Prostatectomy? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - January 25, 2021 Category: General Medicine Source Type: news

What to Expect Prostate Removal Prostatectomy
What to Expect After Prostate Removal (Prostatectomy) (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - January 11, 2021 Category: General Medicine Source Type: news

Comparisons of Analgesic Efficacy in Laparoscopic Prostatectomy Comparisons of Analgesic Efficacy in Laparoscopic Prostatectomy
This study compared postoperative analgesic outcomes of three commonly used anesthesia techniques in patients undergoing robot-assisted laparoscopic prostatectomy.BMC Anesthesiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 22, 2020 Category: Consumer Health News Tags: Anesthesiology Journal Article Source Type: news

Prostate Cancer Pathology Not Worse With Delayed Surgery
Delayed radical prostatectomy not linked to higher risk for adverse pathological outcomes in high - risk prostate cancer (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - December 11, 2020 Category: Cancer & Oncology Tags: Family Medicine, Internal Medicine, Oncology, Pathology, Surgery, Journal, Source Type: news

Prostate Cancer Pathology Not Worse With Delayed Surgery
FRIDAY, Dec. 11, 2020 -- Among men with clinically localized high-risk prostate adenocarcinoma undergoing radical prostatectomy, surgical delay time (SDT) is not associated with a higher risk for adverse pathological features or with worse overall... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 11, 2020 Category: Pharmaceuticals Source Type: news

Safety of delaying surgery for high-risk prostate cancer
(JAMA Network) Considering   when health care resources need to be prioritized during special times, such as the COVID-19 pandemic, researchers in this observational study   looked at whether delaying radical prostatectomy surgery for up to six months for high-risk prostate cancer was associated with worse outcomes. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - December 8, 2020 Category: Infectious Diseases Source Type: news

UCLA, UCSF gain FDA approval for prostate cancer imaging technique
The University of California ’s two nationally ranked medical centers, UCSF and UCLA, and their nuclear medicine teams have obtained approval from the U.S. Food and Drug Administration to offer a new imaging technique for prostate cancer that locates cancer lesions in the pelvic area and other parts of the body to which the t umors have migrated.Known as prostate-specific membrane  antigen PET imaging, or PSMA PET, the technique uses positron emission tomography in conjunction with a PET-sensitive drug that is highly effective in detecting prostate cancer throughout the body so that it can be better and more selectivel...
Source: UCLA Newsroom: Health Sciences - December 1, 2020 Category: Universities & Medical Training Source Type: news